Recent reports have demonstrated that the phosphatidylinositol-3 kinase (PI3K)/AKT pathway is a potent survival signal that may mediate resistance to the apoptotic effects of chemotherapy therapy in different cancer types [9–13]. Here, AKT1 is linked to cancer.